Myriad Genetics, Inc.
MYGN · NASDAQ · USD
$4.25
+0.045 1.07%todayNot financial advice.
- Open
- 4.18
- Day range
- 4.15 - 4.40
- 52-week range
- 2.74 - 8.59
- Volume
- 456.36K
- Market cap
- 406.03M
- P/E ratio
- —
- EPS
- -1.2
- Dividend yield
- 0.00%
- Beta
- 0.34
Performance
W
+2.04%
1M
+36.50%
3M
−30.64%
6M
−4.61%
YTD
−31.20%
Y
−44.22%
5Y
−86.60%
All
−8.69%
In the news
Oct 8
Myriad Genetics and SOPHiA GENETICS Partner on Prostate Cancer Test
Myriad Genetics and SOPHiA GENETICS are collaborating to advance prostate cancer diagnostic technology to expand global access to precision therapies.
Company news
Oct 8
Myriad Genetics Partners with SOPHiA GENETICS and AstraZeneca on Prostate Cancer Test
Myriad Genetics is collaborating with SOPHiA GENETICS and AstraZeneca to develop a prostate cancer genomic instability score for clinical trials.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/NASDAQ-MYGN" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Myriad Genetics, Inc. (MYGN) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-MYGN">MYGN stock price</a> by FreeTheAI Stocks</p>